Treatment type: Cell therapies
-
Importance of donor age in treating BPD
An effective treatment is closer than ever for one of the most devastating conditions affecting premature babies, with researchers at Hudson Institute further refining their world-first method of treating BPD (Bronchopulmonary dysplasia).… Read more
-
Philanthropy supports perinatal brain injury research
Dr Tayla Penny’s perinatal brain injury research has been awarded a significant early career research grant. Dr Penny’s investigation of umbilical cord blood (UCB) cell therapy for perinatal brain injury was recognised by the Jack Brockhoff Foundation as a worthy recipient of a $75,000 grant.… Read more
-
RNA platelet discovery could ease load on blood donors
A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets.… Read more
-
Treatment hope for premature babies
A treatment offering hope to parents of very premature babies is showing great promise, in the first worldwide stocktake of research into umbilical cord blood stem cells.… Read more
-
Chronic lung disease treatment hits speed bump
A promising avenue of research into chronic lung disease treatment has hit a speed bump, with new research showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea that was hoped.… Read more
-
Helping women with endometriosis
Some scientific discoveries have the power to prevent years of pain and suffering. Professor Caroline Gargett and her team are within reach of making that dream a reality for millions of women.… Read more
-
Pelvic organ prolapse prevention and cure
They say prevention is better than cure, but when it comes to pelvic organ prolapse, the specialists at Hudson Institute of Medical Research are taking them equally seriously.… Read more
-
Victorian Premier’s Awards recognise rising stars
Hudson Institute has featured prominently in the Victorian Premier’s Awards for Health and Medical Research, thanks to pioneering work developing new treatments for pelvic organ prolapse (POP).… Read more
-
Placental cell therapy could deliver new treatment options for liver disease
A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.… Read more
-
Veski Fellowship to give POP researcher international experience boosting 3D Bioprinted clinical construct
A researcher developing 3D bioprinted mesh for use in treating pelvic organ prolapse (POP) has received a Victoria Fellowship, allowing him to travel overseas to further his research into bioinks.… Read more